AxoGen, Inc. (AXGN) vs Neogen Corporation (NEOG)
- AxoGen, Inc. AXGN 49.88 +2.32%
- Neogen Corporation NEOG 11.91 +1.97%
AxoGen, Inc. and Neogen Corporation are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.9B against $2.6B — 1.1× the size. AxoGen, Inc. grew revenue faster over the last twelve months: 24.3% against −0.33%. Neogen Corporation has the higher net margin (−6.35% vs −12.0%) and the higher return on invested capital (−0.17% vs −5.27%). Across the 19 metrics below, Neogen Corporation leads on 12 and AxoGen, Inc. on 7.
Valuation
Profitability
| Metric | AXGN | NEOG | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 47.40% | 57.76% |
| Operating margin | (5.17%) | (0.83%) | (15.07%) |
| Net margin | (11.96%) | (6.35%) | (14.45%) |
| Free cash flow margin | 7.50% | 5.64% | (3.88%) |
| Return on equity | (10.35%) | (2.67%) | (10.35%) |
| Return on assets | (8.33%) | (1.68%) | (17.26%) |
| Return on invested capital | (5.27%) | (0.17%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack